CBO: Research Needed On Clinical Impacts, Uptake, Expectations For AOM Drugs

The Congressional Budget Office (CBO) laid out the new research it needs to assess the budgetary effects were Medicare to widely cover anti-obesity medications (AOMs), specifically asking for data on near and long-term clinical impacts, factors affecting use of the drugs and the expectations around the price and effectiveness as they are being developed. CBO specified the research needs during an April 29 roundtable, after saying in March that many questions remain when it comes to CMS covering the drugs,...